Human leukaemia factor as an anti-atherogenic agent (2002–2003)

Grant type:
Prince Charles Hospital Foundation
Researchers:
  • Principal Research Fellow and GL
    Australian Institute for Bioengineering and Nanotechnology
    Principal Research Fellow and Group
    Australian Institute for Bioengineering and Nanotechnology
Funded by:
The Prince Charles Hospital Foundation